Kovitz Investment Group Partners LLC Has $19.78 Million Stock Position in CVS Health Corporation $CVS

Kovitz Investment Group Partners LLC increased its holdings in shares of CVS Health Corporation (NYSE:CVS) by 27.4% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 262,363 shares of the pharmacy operator’s stock after purchasing an additional 56,476 shares during the period. Kovitz Investment Group Partners LLC’s holdings in CVS Health were worth $19,780,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in CVS. Harbor Capital Advisors Inc. raised its stake in CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares during the period. Corundum Trust Company INC acquired a new position in shares of CVS Health in the third quarter valued at $29,000. Front Row Advisors LLC raised its position in shares of CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares during the period. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of CVS Health during the 2nd quarter worth about $36,000. Finally, SOA Wealth Advisors LLC. boosted its holdings in shares of CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after buying an additional 131 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Down 0.9%

Shares of NYSE:CVS opened at $76.64 on Monday. CVS Health Corporation has a 52-week low of $58.35 and a 52-week high of $85.15. The stock has a market capitalization of $97.50 billion, a price-to-earnings ratio of 55.53, a PEG ratio of 0.80 and a beta of 0.50. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The stock’s 50-day simple moving average is $78.52 and its two-hundred day simple moving average is $76.87.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.09. The firm had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business’s quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health’s payout ratio is 192.75%.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. JPMorgan Chase & Co. increased their price target on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a report on Wednesday, December 17th. Wells Fargo & Company lowered their target price on CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research note on Thursday, November 13th. Mizuho boosted their price target on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Wolfe Research increased their price objective on CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, December 8th. Finally, Raymond James Financial lifted their target price on CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.91.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.